FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2068279934> ?p ?o ?g. }

• W2068279934 endingPage "368" @default.
• W2068279934 startingPage "362" @default.
• W2068279934 abstract "To determine if 6 courses of chemotherapy alone could achieve the same or better outcome than 4 courses of chemotherapy followed by radiation therapy (chemoradiotherapy) in pediatric and adolescent patients with Hodgkin disease. Children ≤21 years old with biopsy-proven, pathologically staged I, IIA, or IIIA1 Hodgkin disease were randomly assigned 6 courses of alternating nitrogen mustard, oncovin, prednisone, and procarbazine/doxorubicin, bleomycin, vinblastine, and dacarbazine (treatment 1) or 4 courses of alternating nitrogen mustard, oncovin, prednisone, and procarbazine/doxorubicin, bleomycin, vinblastine, and dacarbazine +2550 cGy involved-field radiotherapy (treatment 2). The complete response rate was 89%, with a complete response and partial response rate of 99.4%. There was no statistically significant difference in event-free survival (EFS) or overall survival between arms. The EFS for those who achieved an early complete response was significantly higher than for those who did not. For pediatric patients with asymptomatic low-stage and intermediate-stage Hodgkin disease, chemotherapy and chemoradiotherapy both resulted in 3-year EFS of approximately 90% and statistically indistinguishable 8-year EFS and overall survival, without significant long-term toxicity. Early response to therapy was associated with higher EFS, a concept that has led to the Children's Oncology Group paradigm of response-based risk-adapted therapy for pediatric Hodgkin disease." @default.
• W2068279934 created "2016-06-24" @default.
• W2068279934 creator A5003639088 @default.
• W2068279934 creator A5014907307 @default.
• W2068279934 creator A5025395169 @default.
• W2068279934 creator A5029772153 @default.
• W2068279934 creator A5041817195 @default.
• W2068279934 creator A5046874953 @default.
• W2068279934 creator A5048575178 @default.
• W2068279934 creator A5049201881 @default.
• W2068279934 creator A5065627357 @default.
• W2068279934 creator A5086993798 @default.
• W2068279934 date "2006-06-01" @default.
• W2068279934 modified "2023-09-23" @default.
• W2068279934 title "POG 8625: A Randomized Trial Comparing Chemotherapy With Chemoradiotherapy for Children and Adolescents With Stages I, IIA, IIIA1 Hodgkin Disease" @default.
• W2068279934 cites W1758481168 @default.
• W2068279934 cites W1827095708 @default.
• W2068279934 cites W1878173168 @default.
• W2068279934 cites W1917085797 @default.
• W2068279934 cites W1940006474 @default.
• W2068279934 cites W1965965711 @default.
• W2068279934 cites W2012305037 @default.
• W2068279934 cites W2016346747 @default.
• W2068279934 cites W2035404108 @default.
• W2068279934 cites W2036284821 @default.
• W2068279934 cites W2054310563 @default.
• W2068279934 cites W2068194578 @default.
• W2068279934 cites W2068676033 @default.
• W2068279934 cites W2076624014 @default.
• W2068279934 cites W2082033443 @default.
• W2068279934 cites W2092015388 @default.
• W2068279934 cites W2092389377 @default.
• W2068279934 cites W2097259789 @default.
• W2068279934 cites W2128719630 @default.
• W2068279934 cites W2254855631 @default.
• W2068279934 cites W2260156623 @default.
• W2068279934 cites W2261683501 @default.
• W2068279934 cites W2262664313 @default.
• W2068279934 cites W2269404396 @default.
• W2068279934 cites W2271171718 @default.
• W2068279934 cites W2320850819 @default.
• W2068279934 cites W238056836 @default.
• W2068279934 cites W2410785440 @default.
• W2068279934 cites W4239468879 @default.
• W2068279934 cites W4293241248 @default.
• W2068279934 cites W2020184805 @default.
• W2068279934 doi "https://doi.org/10.1097/00043426-200606000-00008" @default.
• W2068279934 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16794504" @default.
• W2068279934 hasPublicationYear "2006" @default.
• W2068279934 type Work @default.
• W2068279934 sameAs 2068279934 @default.
• W2068279934 citedByCount "74" @default.
• W2068279934 countsByYear W20682799342012 @default.
• W2068279934 countsByYear W20682799342013 @default.
• W2068279934 countsByYear W20682799342014 @default.
• W2068279934 countsByYear W20682799342015 @default.
• W2068279934 countsByYear W20682799342016 @default.
• W2068279934 countsByYear W20682799342017 @default.
• W2068279934 countsByYear W20682799342018 @default.
• W2068279934 countsByYear W20682799342019 @default.
• W2068279934 countsByYear W20682799342020 @default.
• W2068279934 countsByYear W20682799342021 @default.
• W2068279934 countsByYear W20682799342022 @default.
• W2068279934 countsByYear W20682799342023 @default.
• W2068279934 crossrefType "journal-article" @default.
• W2068279934 hasAuthorship W2068279934A5003639088 @default.
• W2068279934 hasAuthorship W2068279934A5014907307 @default.
• W2068279934 hasAuthorship W2068279934A5025395169 @default.
• W2068279934 hasAuthorship W2068279934A5029772153 @default.
• W2068279934 hasAuthorship W2068279934A5041817195 @default.
• W2068279934 hasAuthorship W2068279934A5046874953 @default.
• W2068279934 hasAuthorship W2068279934A5048575178 @default.
• W2068279934 hasAuthorship W2068279934A5049201881 @default.
• W2068279934 hasAuthorship W2068279934A5065627357 @default.
• W2068279934 hasAuthorship W2068279934A5086993798 @default.
• W2068279934 hasConcept C126322002 @default.
• W2068279934 hasConcept C141071460 @default.
• W2068279934 hasConcept C143998085 @default.
• W2068279934 hasConcept C2776232574 @default.
• W2068279934 hasConcept C2776305933 @default.
• W2068279934 hasConcept C2776694085 @default.
• W2068279934 hasConcept C2776755627 @default.
• W2068279934 hasConcept C2777132456 @default.
• W2068279934 hasConcept C2778424827 @default.
• W2068279934 hasConcept C2778720950 @default.
• W2068279934 hasConcept C2779112685 @default.
• W2068279934 hasConcept C2779429289 @default.
• W2068279934 hasConcept C2780964509 @default.
• W2068279934 hasConcept C509974204 @default.
• W2068279934 hasConcept C71924100 @default.
• W2068279934 hasConceptScore W2068279934C126322002 @default.
• W2068279934 hasConceptScore W2068279934C141071460 @default.
• W2068279934 hasConceptScore W2068279934C143998085 @default.
• W2068279934 hasConceptScore W2068279934C2776232574 @default.
• W2068279934 hasConceptScore W2068279934C2776305933 @default.
• W2068279934 hasConceptScore W2068279934C2776694085 @default.
• W2068279934 hasConceptScore W2068279934C2776755627 @default.
• W2068279934 hasConceptScore W2068279934C2777132456 @default.

• next